Metastatic Breast Cancer, Triple Negative Breast Cancer Completed Phase 2 / 3 Trials for Gemcitabine (DB00441)

Also known as: Metastatic Triple-negative Breast Cancer / Metastatic Triple Negative Breast Cancer / Triple-negative Metastatic Breast Cancer / Triple Negative Metastatic Breast Cancer

IndicationStatusPhase
DBCOND0074793 (Metastatic Breast Cancer, Triple Negative Breast Cancer)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01881230Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)Treatment